NADAC acquisition cost data for PROMETHAZINE 25 MG/ML AMPUL. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00641094835 | $1.78 | 2021-09-22 | Rx |
| 00641149535 | $1.78 | 2021-09-22 | Rx |
| 39822552503 | $1.78 | 2021-09-22 | Rx |
| 00641094835 | $1.78 | 2021-09-22 | Rx |
| 00641149535 | $1.78 | 2021-09-22 | Rx |
| 39822552503 | $1.78 | 2021-09-22 | Rx |
| 00641094835 | $1.78 | 2021-09-22 | Rx |
| 00641149535 | $1.78 | 2021-09-22 | Rx |
| 39822552503 | $1.78 | 2021-09-22 | Rx |
| 00641094835 | $1.78 | 2021-09-22 | Rx |
Generic: Promethazine HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $17.4M | 1,495,922 | 565,436 | $0.3192 |
| 2020 | $17.1M | 1,431,996 | 504,734 | $0.2969 |
| 2021 | $16.5M | 1,417,603 | 515,884 | $0.2772 |
| 2022 | $17.5M | 1,431,004 | 538,484 | $0.2851 |
| 2023 | $16.5M | 1,396,951 | 523,738 | $0.2694 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.